Novo Nordisk has requested the FDA to block creation of compounded copies of copyright, arguing that it’s too tricky to do safely. It’s the latest escalation in a very brewing war among pharmaceutical companies and compounders.Investigators haven't identified a offender in the health problems documented in dozens of states. But officials say in